文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

小而密的低密度脂蛋白胆固醇是前瞻性弗雷明汉后代研究中最具致动脉粥样硬化作用的脂蛋白参数。

Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.

机构信息

Cardiovascular Nutrition Laboratory Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University Boston MA.

Tufts University School of Medicine Boston MA.

出版信息

J Am Heart Assoc. 2021 Feb;10(5):e019140. doi: 10.1161/JAHA.120.019140. Epub 2021 Feb 15.


DOI:10.1161/JAHA.120.019140
PMID:33586462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8174280/
Abstract

Background Elevated plasma levels of direct low-density lipoprotein cholesterol (LDL-C), small dense LDL-C (sdLDL-C), low-density lipoprotein (LDL) triglycerides, triglycerides, triglyceride-rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and lipoprotein(a) have all been associated with incident atherosclerotic cardiovascular disease (ASCVD). Our goal was to assess which parameters were most strongly associated with ASCVD risk. Methods and Results Plasma total cholesterol, triglycerides, high-density lipoprotein cholesterol, direct LDL-C, sdLDL-C, LDL triglycerides, remnant lipoprotein particle cholesterol, triglyceride-rich lipoprotein cholesterol, and lipoprotein(a) were measured using standardized automated analysis (coefficients of variation, <5.0%) in samples from 3094 fasting subjects free of ASCVD. Of these subjects, 20.2% developed ASCVD over 16 years. On univariate analysis, all ASCVD risk factors were significantly associated with incident ASCVD, as well as the following specialized lipoprotein parameters: sdLDL-C, LDL triglycerides, triglycerides, triglyceride-rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and direct LDL-C. Only sdLDL-C, direct LDL-C, and lipoprotein(a) were significant on multivariate analysis and net reclassification after adjustment for standard risk factors (age, sex, hypertension, diabetes mellitus, smoking, total cholesterol, and high-density lipoprotein cholesterol). Using the pooled cohort equation, many specialized lipoprotein parameters individually added significant information, but no parameter added significant information once sdLDL-C (hazard ratio, 1.42; <0.0001) was in the model. These results for sdLDL-C were confirmed by adjusted discordance analysis versus calculated non-high-density lipoprotein cholesterol, in contrast to LDL triglycerides. Conclusions sdLDL-C, direct LDL-C, and lipoprotein(a) all contributed significantly to ASCVD risk on multivariate analysis, but no parameter added significant risk information to the pooled cohort equation once sdLDL-C was in the model. Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter.

摘要

背景:血浆中直接低密度脂蛋白胆固醇(LDL-C)、小而密的 LDL-C(sdLDL-C)、低密度脂蛋白(LDL)甘油三酯、甘油三酯、富含甘油三酯的脂蛋白胆固醇、残粒脂蛋白颗粒胆固醇和脂蛋白(a)的水平升高均与动脉粥样硬化性心血管疾病(ASCVD)的发生有关。我们的目标是评估哪些参数与 ASCVD 风险的相关性最强。

方法和结果:在 3094 名无 ASCVD 的空腹受试者的样本中,使用标准化自动分析(变异系数<5.0%)测量血浆总胆固醇、甘油三酯、高密度脂蛋白胆固醇、直接 LDL-C、sdLDL-C、LDL 甘油三酯、残粒脂蛋白颗粒胆固醇、富含甘油三酯的脂蛋白胆固醇和脂蛋白(a)。在这些受试者中,有 20.2%在 16 年内发生了 ASCVD。在单变量分析中,所有 ASCVD 危险因素均与 ASCVD 的发生显著相关,以及以下特殊脂蛋白参数:sdLDL-C、LDL 甘油三酯、甘油三酯、富含甘油三酯的脂蛋白胆固醇、残粒脂蛋白颗粒胆固醇和直接 LDL-C。只有 sdLDL-C、直接 LDL-C 和脂蛋白(a)在多变量分析和调整标准危险因素(年龄、性别、高血压、糖尿病、吸烟、总胆固醇和高密度脂蛋白胆固醇)后的净重新分类中具有统计学意义。使用合并队列方程,许多特殊脂蛋白参数单独提供了重要信息,但在 sdLDL-C(危险比 1.42;<0.0001)进入模型后,没有参数提供了显著的信息。sdLDL-C 的这些结果通过与计算得出的非高密度脂蛋白胆固醇相比,经过调整的不一致性分析得到了证实,而 LDL 甘油三酯则不然。

结论:sdLDL-C、直接 LDL-C 和脂蛋白(a)在多变量分析中均对 ASCVD 风险有显著贡献,但在 sdLDL-C 进入模型后,没有参数为合并队列方程提供了显著的风险信息。我们的数据表明,小而密的 LDL 是最具致动脉粥样硬化性的脂蛋白参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad34/8174280/de38859fb1b2/JAH3-10-e019140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad34/8174280/8eaab127a6fc/JAH3-10-e019140-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad34/8174280/3900638a7a7e/JAH3-10-e019140-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad34/8174280/de38859fb1b2/JAH3-10-e019140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad34/8174280/8eaab127a6fc/JAH3-10-e019140-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad34/8174280/3900638a7a7e/JAH3-10-e019140-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad34/8174280/de38859fb1b2/JAH3-10-e019140-g003.jpg

相似文献

[1]
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.

J Am Heart Assoc. 2021-2

[2]
Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling project.

Atherosclerosis. 2023-2

[3]
Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression.

J Atheroscler Thromb. 2020-10-1

[4]
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.

J Am Coll Cardiol. 2020-5-5

[5]
Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.

Lipids Health Dis. 2019-7-17

[6]
Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan.

J Atheroscler Thromb. 2019-2-7

[7]
Validation of Estimated Small Dense Low-Density Lipoprotein Cholesterol Concentration in a Japanese General Population.

J Atheroscler Thromb. 2024-6-1

[8]
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test.

Clin Chem. 2021-7-6

[9]
New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis.

Arterioscler Thromb Vasc Biol. 2013-11-14

[10]
Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.

Atherosclerosis. 2009-2

引用本文的文献

[1]
Estimated Small, Dense LDL Cholesterol and Atherosclerotic Cardiovascular Risk in the UK Biobank.

Arterioscler Thromb Vasc Biol. 2025-8-14

[2]
Association between long-term atherogenic index of plasma and carotid atherosclerosis: a prospective cohort study of a health examination population.

BMJ Open. 2025-7-30

[3]
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review.

Curr Atheroscler Rep. 2025-6-9

[4]
Atherogenic lipid parameters in people with normal glucose tolerance: implications from elevated 1-hour post-load plasma glucose.

Cardiovasc Diabetol. 2025-5-14

[5]
Lifestyle Modification in Prediabetes and Diabetes: A Large Population Analysis.

Nutrients. 2025-4-11

[6]
Atherogenic Index of Plasma (AIP) as a Long-Term Prognostic Factor Following CABG: Unveiling Insights From a Large-Scale Tertiary Center Registry Analysis.

Health Sci Rep. 2025-4-16

[7]
Inclisiran in Cardiovascular Health: A Review of Mechanisms, Efficacy, and Future Prospects.

Med Sci Monit. 2025-4-13

[8]
High-Density Lipoprotein Particles, Inflammation, and Coronary Heart Disease Risk.

Nutrients. 2025-3-28

[9]
Diabetes Mellitus Risk Prediction in the Framingham Offspring Study and Large Population Analysis.

Nutrients. 2025-3-24

[10]
Association of estimated small dense low-density lipoprotein cholesterol with diabetes mellitus: a large-scale multicenter retrospective cohort study.

BMC Endocr Disord. 2025-3-11

本文引用的文献

[1]
Development and Population Results of a Fully Automated Homogeneous Assay for LDL Triglyceride.

J Appl Lab Med. 2018-3-1

[2]
Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study.

J Am Coll Cardiol. 2020-6-9

[3]
Direct Versus Calculated LDL Cholesterol and C-Reactive Protein in Cardiovascular Disease Risk Assessment in the Framingham Offspring Study.

Clin Chem. 2019-6-25

[4]
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Circulation. 2018-11-10

[5]
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.

J Am Coll Cardiol. 2018-7-10

[6]
The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.

Clin Chim Acta. 2017-11-22

[7]
Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

J Lipid Res. 2017-7

[8]
Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women.

Clin Chem. 2017-4

[9]
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

JAMA. 2016-9-27

[10]
Evaluating Discrimination of Risk Prediction Models: The C Statistic.

JAMA. 2015-9-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索